---
reference_id: "PMID:16097361"
title: Hypertensive heart disease.
authors:
- Diamond JA
- Phillips RA
journal: Hypertens Res
year: '2005'
doi: 10.1291/hypres.28.191
content_type: abstract_only
---

# Hypertensive heart disease.
**Authors:** Diamond JA, Phillips RA
**Journal:** Hypertens Res (2005)
**DOI:** [10.1291/hypres.28.191](https://doi.org/10.1291/hypres.28.191)

## Content

1. Hypertens Res. 2005 Mar;28(3):191-202. doi: 10.1291/hypres.28.191.

Hypertensive heart disease.

Diamond JA(1), Phillips RA.

Author information:
(1)Division of Cardiology, Long Island Jewish Hospital, New Hyde Park, New York 
10040, USA. jdiamond@lij.edu

Left ventricular hypertrophy (LVH) and diastolic dysfunction (CHF-D) are the 
early manifestations of cardiovascular target organ damage in patients with 
arterial hypertension and signify hypertensive heart disease. Identification of 
hypertensive heart disease is critical, as these individuals are more prone to 
congestive heart failure, arrhythmias, myocardial infarction and sudden cardiac 
death. Regression of left ventricular (LV) mass with antihypertensive therapy 
decreases the risk of future cardiovascular events. The goal of antihypertensive 
therapy is to both lower blood pressure (BP) and interrupt BP-independent 
pathophysiologic processes that promote LVH and CHF-D. The purpose of this 
review is to summarize current and emerging approaches to the pathophysiology 
and treatment of hypertensive heart disease.

DOI: 10.1291/hypres.28.191
PMID: 16097361 [Indexed for MEDLINE]